Aldeyra Therapeutics, Inc. · NASDAQ:ALDX
BlackRock, Inc.'s stake in Aldeyra Therapeutics, Inc. fell to 1.70% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 27, 2026
BlackRock, Inc.'s stake in Aldeyra Therapeutics, Inc. fell to 1.70%, 1,045,764 shares, as a passive investor on Jun 30, 2026. Filed Jul 27, 2026 (Schedule 13G/A).
- Stake
- 1.70%
- Shares
- 1,045,764
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 1.70% | 1,045,764 |
Source
Related
- Aldeyra Therapeutics, Inc.
- BlackRock, Inc.
- Aldeyra Therapeutics, Inc. shareholders
- Schedule 13G · AQR Capital Management LLC · Aug 12, 2026
- Form 4 · Brady Todd C · Jun 5, 2026
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Feb 17, 2026